ABL Diagnostics (XPAR:ABLD) Owner Earnings per Share (TTM): 0.05 (As of Dec. 2025) — 100% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ABLD ABL Diagnostics XPAR:ABLD
50 GF Score
Price €2.34
GF Value €8.21
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is ABL Diagnostics Owner Earnings per Share (TTM)?

ABL Diagnostics XPAR:ABLD +6.36% 50 Owner Earnings per Share (TTM) is 0.05 as of Dec. 2025, which is 100% below its 10-year median of 52.22. GuruFocus rates XPAR:ABLD with a GF Score™ of 50/100 and a GF Value™ of €8.21 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 303 Healthcare Providers & Services companies, ABL Diagnostics ranks worse than 81.52% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

ABL Diagnostics's Owner Earnings per Share (TTM) ended in Dec. 2025 was €0.05. It's Price-to-Owner-Earnings ratio for today is 46.8.


The historical rank and industry rank for ABL Diagnostics's Owner Earnings per Share (TTM) or its related term are showing as below:

XPAR:ABLD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.72   Med: 52.22   Max: 229.4
Current: 43.33


During the past 13 years, the highest Price-to-Owner-Earnings ratio of ABL Diagnostics was 229.40. The lowest was 5.72. And the median was 52.22.


XPAR:ABLD's Price-to-Owner-Earnings is ranked worse than
81.52% of 303 companies
in the Healthcare Providers & Services industry
Industry Median: 17.93 vs XPAR:ABLD: 43.33

ABL Diagnostics's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was €0.04. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.06. It's PE Ratio (TTM) ratio for today is 38.36.

ABL Diagnostics's EPS without NRI for the six months ended in Dec. 2025 was €0.05. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was €0.06. It's PE Ratio without NRI ratio for today is 38.36.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


ABL Diagnostics Owner Earnings per Share (TTM) Related Terms


ABL Diagnostics Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for ABL Diagnostics's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABL Diagnostics Owner Earnings per Share (TTM) Chart

ABL Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 0.06 0.00 -0.12 0.05

ABL Diagnostics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.12 0.00 0.05

XPAR:ABLD vs VEEV, BTSG, HQY: Owner Earnings per Share (TTM) Comparison

For the Health Information Services subindustry, ABL Diagnostics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Diagnostics Price-to-Owner-Earnings vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's Price-to-Owner-Earnings falls into.


XPAR:ABLD
50GF Score
ABL Diagnostics XPAR:ABLD
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ABL Diagnostics Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

ABL Diagnostics's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 0.99
Depreciation, Depletion and Amortization 0.61
Change In Deferred Tax 0.00
5Y Average of Maintenance Capital Expenditure 0.83
Change In Working Capital 0.10
Shares Outstanding (Diluted Average) 16.07

1. Start with "Net Income" from income statement. ABL Diagnostics's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was €0.99 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. ABL Diagnostics's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Dec. 2025 was €0.61 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. ABL Diagnostics's Change In Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = €0.83 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

ABL Diagnostics's 5-Year Average Maintenance Capital Expenditure = €0.83 Mil

5. "Change In Working Capital" is from cashflow statement. ABL Diagnostics's Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2025 was €0.10 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. ABL Diagnostics's Shares Outstanding (Diluted Average) for the months ended in Dec. 2025 was 16.069 Mil.

ABL Diagnostics's Onwer Earnings Per Share for Dec. 2025 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 0.987 +0.61+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-0.8295+0.1)/16.069
=0.05

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=2.34/0.05
=46.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of 0.05 mean?
ABL Diagnostics (XPAR:ABLD) has a Owner Earnings per Share (TTM) of 0.05 as of Dec. 2025. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on ABL Diagnostics. This is 100% below median its historical median of 52.22. Over the past decade, ABL Diagnostics' Owner Earnings per Share (TTM) has ranged from 5.72 to 229.40. According to the industry distribution chart, ABL Diagnostics ranks #247 out of 303 companies in the Healthcare Providers & Services industry, placing it in the top 81.5%.
Is ABL Diagnostics' Owner Earnings per Share (TTM) too high?
ABL Diagnostics' current Owner Earnings per Share (TTM) of 0.05 is 100% below median its 10-year median of 52.22. Over the past 10 years, this metric has ranged from a low of 5.72 to a high of 229.40. The Healthcare Providers & Services industry median Owner Earnings per Share (TTM) is 17.93. ABL Diagnostics' value of 0.05 is 99.7% below this industry median. Based on the distribution chart, ABL Diagnostics ranks #247 out of 303 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, ABL Diagnostics has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ABL Diagnostics' Owner Earnings per Share (TTM) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ABL Diagnostics ranks #247 out of 303 companies for Owner Earnings per Share (TTM). This places ABL Diagnostics in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 17.93. ABL Diagnostics' value of 0.05 is 99.7% below this benchmark. Historically, ABL Diagnostics' own Owner Earnings per Share (TTM) has ranged from 5.72 to 229.40 over the past decade. While the company's 10-year median is 52.22 vs. the industry median of 17.93, ABL Diagnostics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Healthcare Providers & Services company?
The median Owner Earnings per Share (TTM) among Healthcare Providers & Services companies is 17.93, based on 303 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABL Diagnostics's current Owner Earnings per Share (TTM) of 0.05 is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on ABL Diagnostics. For the Healthcare Providers & Services industry, the median Owner Earnings per Share (TTM) is 17.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABL Diagnostics's current Owner Earnings per Share (TTM) is 0.05, which is 100% below median its own 10-year median of 52.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABL Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, ABL Diagnostics (XPAR:ABLD) is currently considered Significantly Undervalued. The stock's GF Value™ is €8.21, compared to a current price of €2.34 — trading 71.5% below its estimated fair value. The current Owner Earnings per Share (TTM) is 0.05, which is 100% below median its 10-year median of 52.22 and 99.7% below the Healthcare Providers & Services industry median of 17.93. ABL Diagnostics' overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For ABL Diagnostics (XPAR:ABLD), the current Owner Earnings per Share (TTM) is 0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ABL Diagnostics (XPAR:ABLD) Overvalued in 2026?

Based on GuruFocus' analysis, ABL Diagnostics stock appears to be undervalued. The current stock price of €2.34 is trading 71.5% below its estimated GF Value™ of €8.21. GuruFocus considers ABL Diagnostics to be Significantly Undervalued.

Key valuation signals for XPAR:ABLD:

  • Owner Earnings per Share (TTM): 0.05 (100% below median its 10-year median of 52.22)
  • GF Value™: €8.21 vs. price of €2.34 (71.5% below fair value)
  • GF Score™: 50/100 with 4 warning signs
  • Industry Position: 99.7% below the Healthcare Providers & Services median (#247 of 303)

No single metric tells the full story. See the XPAR:ABLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ABL Diagnostics Business Description

Other Exchanges 9BK0:Germany
Address 72c, rue de, WOIPPY, Thionville, FRA, 57140
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
50GF Score

Get the complete analysis for XPAR:ABLD

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.34
Price
€8.21
GF Value